Patents by Inventor Do Un Kim
Do Un Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240075920Abstract: A method for controlling driving of a hybrid electric vehicle includes collecting driving data while the hybrid electric vehicle is driven, determining whether the hybrid electric vehicle enters a first mode corresponding to emergency driving of the hybrid electric vehicle or a second mode corresponding to control in preparation for the emergency driving, and controlling the hybrid electric vehicle in accordance with a mode that the hybrid electric vehicle enters among the first mode and the second mode.Type: ApplicationFiled: January 31, 2023Publication date: March 7, 2024Applicants: HYUNDAI MOTOR COMPANY, KIA CORPORATIONInventors: Sung Bae Jeon, Seong Wook Moon, Do Hwa Kim, Gyu Ri Lee, Sung Il Jung, Jae Young Park, Jeong Eun Kim, Hui Un Son
-
Patent number: 11622984Abstract: The present invention relates to a composition comprising Aster sphathulifolius Maxim extract for preventing, improving, or treating muscular diseases and for improving muscular functions. The Aster sphathulifolius Maxim extract according to the present invention exhibits effects of inhibiting the expression of muscle protein breakdown-related factors and increasing the expression of muscle protein synthesis-related factors, as well as alleviating the reduction of muscle tissue weight and cross-sectional area of muscle fibers, and thus can be useful for preventing, improving, or treating muscular diseases and improving muscular functions.Type: GrantFiled: May 20, 2019Date of Patent: April 11, 2023Assignee: NEWTREE CO., LTD.Inventors: Woo Chang Jung, Do Un Kim, Hee Chul Chung
-
Publication number: 20210228666Abstract: The present invention relates to a composition comprising Aster sphathulifolius Maxim extract for preventing, improving, or treating muscular diseases and for improving muscular functions. The Aster sphathulifolius Maxim extract according to the present invention exhibits effects of inhibiting the expression of muscle protein breakdown-related factors and increasing the expression of muscle protein synthesis-related factors, as well as alleviating the reduction of muscle tissue weight and cross-sectional area of muscle fibers, and thus can be useful for preventing, improving, or treating muscular diseases and improving muscular functions.Type: ApplicationFiled: May 20, 2019Publication date: July 29, 2021Inventors: Woo Chang JUNG, Do Un KIM, Hee Chui CHUNG
-
Patent number: 9452193Abstract: The present invention relates to the novel use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue and enhancing exercise performance, and more particularly to a composition for promoting an increase in muscles, anti-fatigue composition and a composition for enhancing muscle mass growth and recovery from fatigue to improve exercise performance, the composition comprising a panduratin derivative or a salt thereof or an extract of Boesenbergia pandurata as an active ingredient, and to a method for enhancing muscle mass growth, of treating or preventing fatigue syndrome and enhancing exercise performance, the method comprising a panduratin derivative or a salt thereof or a extract of Boesenbergia pandurata to a subject in need thereof.Type: GrantFiled: September 4, 2015Date of Patent: September 27, 2016Assignees: Biocare Co., Ltd., Newtree Co., Ltd.Inventors: Jae-Kwan Hwang, Do Un Kim
-
Publication number: 20160271028Abstract: The present invention relates to a new use of panduratin derivatives or a Kaempferia pandurata extract comprising the same. More particularly, the present invention relates to a composition for improving wrinkles and/or preventing aging, which comprises a panduratin derivative or a Kaempferia pandurata extract comprising the same. The said the panduratin derivative or the Kaempferia pandurata extract comprising the same induces cell proliferation, inhibits degradation of collagen, and promotes synthesis of collagen, therefore, it shows excellent activity in prevention of aging, particularly preventing, improving or treating wrinkle and it can be used as an effective ingredient in a cosmetic, food or pharmaceutical composition.Type: ApplicationFiled: December 17, 2015Publication date: September 22, 2016Inventors: Jae Kwan Hwang, Jae-Seok Shim, Song Hui Gwon, Yi Young Kwon, Hyun In Oh, Young Sun Han, Eun Jung Choi, Do Un Kim
-
Publication number: 20150374777Abstract: The present invention relates to the novel use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue and enhancing exercise performance, and more particularly to a composition for promoting an increase in muscles, anti-fatigue composition and a composition for enhancing muscle mass growth and recovery from fatigue to improve exercise performance, the composition comprising a panduratin derivative or a salt thereof or an extract of Boesenbergia pandurata as an active ingredient, and to a method for enhancing muscle mass growth, of treating or preventing fatigue syndrome and enhancing exercise performance, the method comprising a panduratin derivative or a salt thereof or a extract of Boesenbergia pandurata to a subject in need thereof.Type: ApplicationFiled: September 4, 2015Publication date: December 31, 2015Inventors: Jae-Kwan HWANG, Do Un Kim
-
Patent number: 9198880Abstract: The present invention relates to the novel use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue and enhancing exercise performance. A panduratin derivative or a salt thereof or an extract of Boesenbergia pandurata of the present invention may be used without side effect and has the effect of increasing the expression of PPAR-? in muscles to increase muscle mass, promoting recovery from fatigue and increase mobility, thereby improving exercise performance.Type: GrantFiled: November 20, 2012Date of Patent: December 1, 2015Assignees: Biocare Co., Ltd., Newtree Co., Ltd.Inventors: Jae-Kwan Hwang, Do Un Kim
-
Patent number: 8969408Abstract: The present invention relates to a new use of lignan-type compounds or an extract of nutmeg or aril of nutmeg comprising the same. More particularly, the present invention relates to a composition for skin whitening comprising a lignan-type compound or an extract of nutmeg or aril of nutmeg comprising the same. Because the lignan compound represented by Chemical Formulas 1 to 3 or the extract of nutmeg or aril of nutmeg has superior skin whitening activity by inhibiting melanin production and tyrosinase activity, it can be used for the preparation of a cosmetic composition, food composition or pharmaceutical composition for skin whitening.Type: GrantFiled: October 17, 2008Date of Patent: March 3, 2015Assignees: Biocare Co., Ltd., Newtree Co., Ltd.Inventors: Jae Kwan Hwang, Yu-Mi Cho, Gyu Hoi Kim, Jeong Hwan Kim, Hae Ji Lee, Do Un Kim, Hee Chul Chung, Jae Youn Chung, Hyun In Oh
-
Patent number: 8853264Abstract: The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a method for preventing or treating an inflammatory disease, comprising administering to a subject in need thereof an effective amount of macelignan represented by Chemical Formula I or a pharmaceutically acceptable salt thereof. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE2, COX-2 and TNF-? and by treating or preventing inflammatory disease in vivo. Accordingly, the lignan compound or a Myristica fragrans extract will be highly useful for the treatment or prevention of an inflammatory disease.Type: GrantFiled: April 23, 2010Date of Patent: October 7, 2014Assignees: Newtree Industry Co., Ltd.Inventors: Jae-Kwan Hwang, Do-Un Kim, Jae-Youn Chung, Hee-Chul Chung, Kyu-Lee Han
-
Patent number: 8653143Abstract: The present invention relates to a novel use of a panduratin derivative or a Boesenbergia pandurata extract. More specifically, the invention relates to a composition for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, containing a panduratin derivative represented by Chemical Formula 1, 2 or 3 or a Boesenbergia pandurata extract as an active ingredient, a method for treating a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, by administering an effective amount of the panduratin derivative or the Boesenbergia pandurata extract to a subject in need thereof, and a use of the panduratin derivative or the Boesenbergia pandurata extract to prepare a reagent for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes.Type: GrantFiled: October 9, 2009Date of Patent: February 18, 2014Assignees: Newtree Co., Ltd.Inventors: Jae-Kwan Hwang, Do Un Kim
-
Patent number: 8435957Abstract: The present invention relates to a novel use of lignan compounds, which are isolated and purified from nutmeg or the aril of nutmeg for anti-wrinkle, and more particularly, the present invention relates to a novel use for anti-wrinkle of an extract of the nutmeg or an extract of the aril of the nutmeg, fragrin A, austobailignan 7, licarin E, and macelignan. The extracts and lignan compounds of the present invention have activities in suppressing collagen degradation enzyme-1 (MMP-I, matrix metalloprotei-nase-1) and formation of new collagen (type-1 procollagen), thereby having effect on inhibitng wrinkle caused by photoaging. Accordingly, the extracts and lignan compounds of the present invention may be useful for preventing or treating wrinkle caused by photoaging.Type: GrantFiled: June 20, 2008Date of Patent: May 7, 2013Assignees: Biocare Co., Ltd., Newtree Co., Ltd.Inventors: Jae-Kwan Hwang, Hae Ji Lee, Jae Young Lee, Jae-Seok Shim, Jeong Hwan Kim, Do Un Kim, Heechul Chung, Jae Youn Chung
-
Publication number: 20120288579Abstract: The present invention relates to a novel use of lignan compounds, which are isolated and purified from nutmeg or the aril of nutmeg for anti-wrinkle, and more particularly, the present invention relates to a novel use for anti-wrinkle of an extract of the nutmeg or an extract of the aril of the nutmeg, fragrin A, austobailignan 7, licarin E, and macelignan. The extracts and lignan compounds of the present invention have activities in suppressing collagen degradation enzyme-1 (MMP-1, matrix metalloprotei-nase-1) and formation of new collagen (type-1 procollagen), thereby having effect on inhibitng wrinkle caused by photoaging. Accordingly, the extracts and lignan compounds of the present invention may be useful for preventing or treating wrinkle caused by photoaging.Type: ApplicationFiled: June 20, 2009Publication date: November 15, 2012Applicant: BIOCARE CO. LTD.Inventors: Jae-Kwan Hwang, Hae Ji Lee, Jae Young Lee, Jae-Seok Shim, Jeong Hwan Kim, Do Un Kim, Heechul Chung, Jae Youn Chung
-
Publication number: 20120088840Abstract: The present invention relates to a novel use of a panduratin derivative or a Boesenbergia pandurata extract. More specifically, the invention relates to a composition for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, containing a panduratin derivative represented by Chemical Formula 1, 2 or 3 or a Boesenbergia pandurata extract as an active ingredient, a method for treating a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes, by administering an effective amount of the panduratin derivative or the Boesenbergia pandurata extract to a subject in need thereof, and a use of the panduratin derivative or the Boesenbergia pandurata extract to prepare a reagent for preventing and treating/relieving a metabolic disease selected from a group consisting of obesity, hyperlipidemia, hypercholesterolemia and diabetes.Type: ApplicationFiled: October 9, 2009Publication date: April 12, 2012Applicants: JAE-KWAN HWANG, NEWTREE CO., LTD.Inventors: Jae-Kwan Hwang, Do Un Kim
-
Publication number: 20120065272Abstract: The present invention relates to a new use of panduratin derivatives or a Kaempferia pandurata extract comprising the same. More particularly, the present invention relates to a composition for improving wrinkles and/or preventing aging, which comprises a panduratin derivative or a Kaempferia pandurata extract comprising the same. The said the panduratin derivative or the Kaempferia pandurata extract comprising the same induces cell proliferation, inhibits degradation of collagen, and promotes synthesis of collagen, therefore, it shows excellent activity in prevention of aging, particularly preventing, improving or treating wrinkle and it can be used as an effective ingredient in a cosmetic, food or pharmaceutical composition.Type: ApplicationFiled: October 17, 2008Publication date: March 15, 2012Applicant: NEWTREE CO., LTD.Inventors: Jae Kwan Hwang, Jae-Seok Shim, Song Hui Gwon, Yi Young Kwon, Hyun In Oh, Young Sun Han, Eun Jung Choi, Do Un Kim
-
Publication number: 20110118346Abstract: The present invention relates to a new use of lignan-type compounds or an extract of nutmeg or aril of nutmeg comprising the same. More particularly, the present invention relates to a composition for skin whitening comprising a lignan-type compound or an extract of nutmeg or aril of nutmeg comprising the same. Because the lignan compound represented by Chemical Formulas 1 to 3 or the extract of nutmeg or aril of nutmeg has superior skin whitening activity by inhibiting melanin production and tyrosinase activity, it can be used for the preparation of a cosmetic composition, food composition or pharmaceutical composition for skin whitening.Type: ApplicationFiled: October 17, 2008Publication date: May 19, 2011Applicants: BIOCARE CO., LTD., NEWTREE CO., LTD.Inventors: Jae Kwan Hwang, Yu-Mi Cho, Gyu Hoi Kim, Jeong Hwan Kim, Hae Ji Lee, Do Un Kim, Hee Chul Chung, Jae Youn Chung, Hyun In Oh
-
Publication number: 20110071221Abstract: Disclosed is a method for treating PPAR (peroxisome proliferator activated receptor)mediated diseases, such as diabetes mellitus and diabetic complications, which includes administering to a subject an effective amount of macelignan represented by the following Formula (I): or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: June 27, 2006Publication date: March 24, 2011Inventors: Jae-Kwan Hwang, Kyu-Lee Han, Jong-Hee Sohn, Ah-Jin Kim, Jeong-Han Choo, Jae-Young Lee, Jeong-Hwan Kim, Do Un Kim, Heechul Chung, Jae Youn Chung
-
Patent number: 7902254Abstract: Disclosed is a method for treating PPAR (peroxisome proliferator activated receptor)-mediated diseases, such as diabetes mellitus, which includes administering to a subject an effective amount of macelignan represented by the following Formula (I): or a pharmaceutically acceptable salt thereof.Type: GrantFiled: June 27, 2006Date of Patent: March 8, 2011Assignee: Newtree Co., Ltd.Inventors: Jae-Kwan Hwang, Kyu-Lee Han, Jong-Hee Sohn, Ah-Jin Kim, Jeong-Han Choo, Jae-Young Lee, Jeong-Hwan Kim, Do Un Kim, Heechul Chung, Jae Youn Chung
-
Publication number: 20100285154Abstract: The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a method for preventing or treating an inflammatory disease, comprising administering to a subject in need thereof an effective amount of macelignan represented by Chemical Formula I or a pharmaceutically acceptable salt thereof. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE2, COX-2 and TNF-? and by treating or preventing inflammatory disease in vivo. Accordingly, the lignan compound or a Myristica fragrans extract will be highly useful for the treatment or prevention of an inflammatory disease.Type: ApplicationFiled: April 23, 2010Publication date: November 11, 2010Applicants: NEWTREE INDUSTRY CO., LTD., Jae-KwanInventors: Jae-Kwan Hwang, Do-Un Kim, Jae-Youn Chung, Hee-Chul Chung, Kyu-Lee Han
-
Publication number: 20080114058Abstract: The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a pharmaceutical composition for the treatment or prevention of an inflammatory disease, comprising a lignan compound represented by Formula I, as well as a treating method and the use of an inflammatory disease using the lignan compound. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE2, COX-2 and TNF-?. Accordingly, the lignan compound or a Myristica fragrans extract will be highly useful for the treatment or prevention of an inflammatory disease.Type: ApplicationFiled: January 6, 2006Publication date: May 15, 2008Inventors: Jae-Kwan Hwang, Do-Un Kim, Jae-Youn Chung, Hee-Chul Chung, Kyu-Lee Han